Govt. panel suggests increasing gap between two doses of Covishield
The National Technical Advisory Group on Immunisation (NTAGI) on Thursday recommended increasing the gap between the two doses of Covishield to 12-16 weeks as opposed to the current four to eight weeks, a suggestion amidst a vaccine shortage in the country with many states yet to begin vaccinating individuals above 18 years.
The panel has, however, kept the dosage interval for Covaxin unchanged.
NTAGI has also recommended that those who have tested positive for COVID-19 and are waiting to take the vaccine, should defer vaccination for six months after recovery.
The panel said that pregnant women may be offered the choice to take any COVID-19 vaccine and that lactating women can be inoculated any time after delivery.
However, many medical experts across the country have recommended against the use of vaccines during pregnancy as impacts could not be assessed, given that the trials were not conducted to understand effects on pregnant women.
The recommendations of the NTAGI will be sent to the National Expert Group on Vaccine Administration for COVID-19.
ALSO READ: Bharat Biotech to make two crore doses of Covaxin per month at UP plant
ALSO WATCH:
